MAP1LC3A and glioblastoma: Giatromanolaki et al. [35] reported that extensive expression of MAP1LC3A was observed in 43% of GBM samples and that upregulation of MAP1LC3A was associated with impaired autophagic activity, which may facilitate GBM carcinogenesis.